Key Takeaways
- Single-cell spatial proteomics links protein measurements to individual cells and their tissue context.
- Main method families include multiplexed antibody imaging, imaging mass cytometry (IMC), and image-guided isolation followed by mass spectrometry.
- Post-translational modifications and protein localization are not captured by transcript measurements.
- Antibody methods, including IMC with metal-tagged antibodies, measure defined targeted panels at high spatial resolution; mass spectrometry offers broader, untargeted protein coverage from selected material.
- Tissue preparation, imaging quality, and precise cell isolation affect data quality across methods.
Why Protein-Level Spatial Data Matters
The relationship between mRNA and protein abundance varies by gene, cell type, and condition. Protein turnover, translation efficiency, and post-translational modifications all contribute to this variation. For questions about signaling states, drug targets, or functional phenotypes, protein measurements provide information that transcript data cannot.
What Bulk Measurements Average Out
Bulk proteomics averages across many cells, which can hide:
- Rare cell populations
- Cell-to-cell differences in signaling states
- Tumor subpopulations with different treatment responses
Spatial methods add the location of each cell. An immune cell inside a tumor nest and one at the tumor margin may express different proteins, but that difference is lost once tissue is dissociated.
Main Method Families
Antibody-Based Imaging
Multiplexed immunofluorescence uses repeated cycles of staining and imaging, or DNA-barcoded antibodies revealed in cycles, to measure many proteins in one section.
Imaging mass cytometry (IMC) labels antibodies with metal isotopes. A laser ablates the tissue spot by spot, and time-of-flight mass spectrometry measures the metals to reconstruct an image. Because no fluorophores are used, spectral overlap does not limit the panel. IMC is a targeted antibody method, not untargeted discovery proteomics (Nature Methods).
Suspension mass cytometry (CyTOF) measures many metal-tagged markers per cell, but cells are dissociated, so spatial information is lost.
Antibody-based methods measure predefined, targeted panels. Each antibody requires validation for the tissue and fixation used.
Mass Spectrometry-Based Approaches
LC-MS/MS single-cell proteomics identifies proteins without antibodies and can provide broader coverage than fixed antibody panels. Proteins cannot be amplified like nucleic acids, so sensitivity and input amount limit depth. These measurements profile isolated cells or regions; they do not by themselves produce a continuous spatial image across the tissue section. Depth and throughput trade off against each other. Reported protein numbers vary with cell type, sample preparation, labeling strategy, and how protein identifications are counted, so published benchmarks are not directly comparable.
Imaging-Guided Microdissection With Mass Spectrometry
Hybrid workflows combine image analysis, laser microdissection, and mass spectrometry:
- Image analysis classifies cells by phenotype in tissue sections.
- Laser microdissection isolates the selected cells or nuclei.
- Mass spectrometry profiles the proteome of the isolated material.
Imaging-guided microdissection allows researchers to associate downstream protein measurements with cells or tissue regions identified by morphology, staining, or image analysis. After selecting the target material, laser microdissection physically isolates it for separate protein extraction, digestion, and mass-spectrometry analysis.
The spatial information comes from the documented location and phenotype of the selected material. When several cells are collected together, the resulting proteomic profile represents the pooled population rather than an independent protein measurement for every individual cell.
This approach can support studies of tissue heterogeneity and cell-type-associated protein expression, but it does not automatically generate a continuous spatial protein map across the original tissue section.
Applications
- Oncology: characterizing tumor and immune cell phenotypes and their spatial relationships.
- Immunology: mapping immune cell activation states in lymphoid and inflamed tissues.
- Drug discovery: measuring target protein expression and pathway activation in specific cell populations.
Practical Challenges
- Sensitivity: single cells contain small amounts of protein, and proteins cannot be amplified like nucleic acids.
- Throughput: high-plex imaging and single-cell mass spectrometry both require long acquisition times.
- Antibody validation: antibody-based panels depend on validated reagents for each tissue and fixation method.
- Segmentation: assigning signals to individual cells depends on accurate cell-boundary detection, which varies with cell density and shape.
- Data analysis: integrating imaging and proteomic data requires specialized computational workflows.
The Role of Imaging and Microdissection
Data quality depends on the starting material. For mass spectrometry-based workflows, isolating the intended cells without neighboring cells reduces contamination of the proteome profile. For imaging workflows, focus, illumination, and segmentation affect which signals are assigned to each cell.
Laser capture microdissection (LCM) is a microscopy-guided method for isolating selected cells or regions from tissue sections. The isolated material is then analyzed by separate LC-MS/MS or other downstream assays. The resulting proteome is region-associated (linked to documented location and morphology); LCM followed by MS does not automatically generate a continuous tissue-wide molecular map.
Laxco Tools for Spatial Proteomics Workflows
- Accuva Cellect: a laser capture microdissection system with an infrared (IR) laser for capture of single cells or small numbers of cells and a UV laser for cutting dense structures. Laxco lists FFPE and fresh-frozen tissue, several staining types, immunofluorescence, unstained samples, and cell culture as supported. Protein extraction and mass spectrometry are separate laboratory steps after capture; Accuva Cellect does not perform MS itself.
- LEAP AI: combines Accuva LEAP optics with Media Cybernetics Image-Pro AI for pre-trained deep-learning segmentation, measurement, batch processing, and reporting.
- SLi6Pro: an inverted fluorescence microscope with SeBaLIT™ illumination supporting 3-color multiplex fluorescence across approximately 390–662 nm and more than 110 compatible fluorochromes. The 110+ figure is fluorochrome compatibility, not simultaneous imaging of 110 channels.
These are distinct products with different roles. Laxco supplies Accuva Cellect with application training and technical support, including a stated 48-hour response commitment on the product page. Mass spectrometry and other proteomic analyses remain separate laboratory procedures; Laxco does not perform proteomic analysis as a laboratory service.
Frequently Asked Questions
Should I choose antibody imaging or mass spectrometry?
Choose antibody imaging (including multiplex IF and IMC) when you have a defined, validated marker panel and need cell-level spatial maps of those targets. Choose mass spectrometry when you need broader, untargeted protein coverage from selected cells or regions after isolation.
Can LCM isolate single cells for mass spectrometry?
Yes. Laxco's Accuva Cellect infrared laser is designed to capture individual cells or small numbers of cells from tissue sections. However, the ability to isolate one cell does not guarantee that the collected material will contain enough protein for the intended mass-spectrometry analysis.
The required input depends on cell type, protein abundance, sample preparation, instrument sensitivity, and the downstream analytical workflow. Some proteomics methods analyze individual cells, while others require pooled cells or tissue regions to obtain sufficient material.
When cells are pooled, the resulting measurements describe the combined sample rather than a separate proteome for each captured cell. Researchers should validate sample-input requirements with their intended mass-spectrometry workflow before collecting study samples.
Which sample types does Accuva Cellect support for proteomics?
Laxco lists FFPE and fresh-frozen tissue, H&E-stained and LCM-optimized stained sections, immunofluorescence, unstained samples, and cell culture. Its microgenomics workflow includes protein extraction and mass spectrometry as downstream options.
Can AI segmentation select cells for microdissection?
Image analysis can classify cells and help define capture targets. LEAP AI is a separate imaging and analysis platform (Accuva LEAP optics with Media Cybernetics Image-Pro AI); it is not built into Accuva Cellect, does not automatically select cells for Cellect capture, and does not control the Cellect laser. Validate any classification against annotated images from the same tissue and stain before relying on it.
How can I image phenotype markers before isolating cells?
Multichannel immunofluorescence can identify phenotypes before capture. The SLi6Pro supports multichannel fluorescence with SeBaLIT illumination (3-color multiplex; ~390–662 nm; 110+ fluorochrome compatibility), and Accuva Cellect supports immunofluorescence-stained sections for subsequent isolation. Validate that the same targets transfer from imaging phenotype definitions to the isolation workflow before study-scale capture.
